Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High HDL‐cholesterol in women with rheumatoid arthritis on low‐dose glucocorticoid therapy
Carmen García‐Gómez, Joan M. Nolla, J. Valverde, et al.
European Journal of Clinical Investigation (2008) Vol. 38, Iss. 9, pp. 686-692
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Total cholesterol and LDL levels decrease before rheumatoid arthritis
Elena Myasoedova, C. S. Crowson, Hilal Maradit Kremers, et al.
Annals of the Rheumatic Diseases (2009) Vol. 69, Iss. 7, pp. 1310-1314
Open Access | Times Cited: 189
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis
Jos N. Hoes, Johannes W. G. Jacobs, Frank Buttgereit, et al.
Nature Reviews Rheumatology (2010) Vol. 6, Iss. 12, pp. 693-702
Closed Access | Times Cited: 140
Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
George Robinson, Inès Pineda‐Torra, Coziana Ciurtin, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 2
Open Access | Times Cited: 66
Dyslipidemia in rheumatoid arthritis: the possible mechanisms
Jiahui Yan, Sisi Yang, Liang Han, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: A systematic literature review
Adeline Ruyssen‐Witrand, Bruno Fautrel, Alain Saraux, et al.
Joint Bone Spine (2010) Vol. 78, Iss. 1, pp. 23-30
Closed Access | Times Cited: 104
Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy
Laura Durcan, Deborah A. Winegar, Margery A. Connelly, et al.
The Journal of Rheumatology (2016) Vol. 43, Iss. 4, pp. 745-750
Open Access | Times Cited: 67
The role of endothelial function and its assessment in rheumatoid arthritis
Faisel Khan, Bernat Galarraga, J. J. F. Belch
Nature Reviews Rheumatology (2010) Vol. 6, Iss. 5, pp. 253-261
Closed Access | Times Cited: 86
Rheumatoid arthritis and cardiovascular disease
Medha Barbhaiya, Daniel H. Solomon
Current Opinion in Rheumatology (2013) Vol. 25, Iss. 3, pp. 317-324
Open Access | Times Cited: 56
Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?
Carmen García‐Gómez, Maria Lúcia Bianchi, Diana de la Fuente, et al.
World Journal of Orthopedics (2014) Vol. 5, Iss. 3, pp. 304-304
Open Access | Times Cited: 42
Cardiovascular disease in rheumatoid arthritis: a step forward
Elena Myasoedova, Sherine E. Gabriel
Current Opinion in Rheumatology (2010) Vol. 22, Iss. 3, pp. 342-347
Closed Access | Times Cited: 46
Investigation of the Association between Metabolic Syndrome and Disease Activity in Rheumatoid Arthritis
Maryam Sahebari, Ladan Goshayeshi, Zahra Mirfeizi, et al.
The Scientific World JOURNAL (2011) Vol. 11, pp. 1195-1205
Open Access | Times Cited: 44
Lipid Paradox in Rheumatoid Arthritis: Changes With Rheumatoid Arthritis Therapies
Matxalen Amezaga Urruela, María E. Suarez‐Almazor
Current Rheumatology Reports (2012) Vol. 14, Iss. 5, pp. 428-437
Closed Access | Times Cited: 42
Glucocorticoids and Cardiovascular Risk Factors
Erika Strohmayer, Lawrence R. Krakoff
Endocrinology and Metabolism Clinics of North America (2011) Vol. 40, Iss. 2, pp. 409-417
Closed Access | Times Cited: 41
Impact of Systemic Inflammation and Autoimmune Diseases on apoA-I and HDL Plasma Levels and Functions
Fabrizio Montecucco, Elda Favari, Giuseppe Danilo Norata, et al.
Handbook of experimental pharmacology (2014), pp. 455-482
Open Access | Times Cited: 40
Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis
Eliana Botta, Tomás Meroño, Carla Saucedo, et al.
Atherosclerosis (2016) Vol. 251, pp. 438-444
Open Access | Times Cited: 35
Conventional Lipid Profile and Lipoprotein(a) Concentrations in Treated Patients with Rheumatoid Arthritis
Carmen García‐Gómez, Joan M. Nolla, Josep Valverde, et al.
The Journal of Rheumatology (2009) Vol. 36, Iss. 7, pp. 1365-1370
Open Access | Times Cited: 40
The current relevance and use of prednisone in rheumatoid arthritis
Marco Krasselt, Christoph Baerwald
Expert Review of Clinical Immunology (2014) Vol. 10, Iss. 5, pp. 557-571
Closed Access | Times Cited: 33
Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study
Theodosios D. Filippatos, C.S. Derdemezis, PV Voulgari, et al.
Scandinavian Journal of Rheumatology (2013) Vol. 42, Iss. 3, pp. 169-175
Closed Access | Times Cited: 31
The influence of glucocorticoids on lipid and lipoprotein metabolism and atherosclerosis
Ian Louis Ross, A. David Marais
South African Medical Journal (2014) Vol. 104, Iss. 10, pp. 671-671
Open Access | Times Cited: 28
Cholesteryl Ester Transfer Protein in Patients with Rheumatoid Arthritis
Iván Ferraz‐Amaro, Miguel Á. González‐Gay, José A. García-Dopico, et al.
The Journal of Rheumatology (2013) Vol. 40, Iss. 7, pp. 1040-1047
Open Access | Times Cited: 27
Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment
Mio Akiyama, Taro Mawatari, Yasuharu Nakashima, et al.
Clinical Rheumatology (2015) Vol. 34, Iss. 11, pp. 1867-1875
Closed Access | Times Cited: 25
Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy
Onorina Berardicurti, Piero Ruscitti, Viktoriya Pavlych, et al.
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 6, pp. 593-604
Closed Access | Times Cited: 23
Hormone therapy in rheumatic diseases
Maurizio Cutolo
Current Opinion in Rheumatology (2010) Vol. 22, Iss. 3, pp. 257-263
Closed Access | Times Cited: 23
Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center
Stephanie Keeling, Michelle Teo, Daisy Fung
Clinical Rheumatology (2011) Vol. 30, Iss. 10, pp. 1311-1317
Open Access | Times Cited: 21
Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients
Lisa L. Schroeder, Xiaoqin Tang, Mary Chester Wasko, et al.
Rheumatology International (2014) Vol. 35, Iss. 6, pp. 1059-1067
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top